REQUEST A DEMO
Total
USD $0.00
Search more companies

Sancak Ecza Deposu A.S. (Turkiye)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Sancak Ecza Deposu Anonim Sirketi Profile Updated: August 01, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

With its understanding of quality and fast service, it established pharmaceutical warehouses in many provinces and expanded its service network in a short time. Sancak Group, which started to shape the dynamics of the sector as the leading brand of the sector in 2001; It established a partnership with the leading international distribution channel of the world pharmaceutical industry. In 2013, the group took a break from its pharmaceutical distribution activities by selling all its shares to its business partner. Sancak Pharmaceutical Warehouse, which started operating again in 2019 and offers a wide range of alternatives, delivery speed and high efficiency with over 15,000 pharmaceutical and non-pharmaceutical products; He always works hard to be at the top with his professional work ethic.

Headquarters
No:5-z1 Baglar Mahallesi 63. Sokak Bagcilar
Istanbul; Marmara; Postal Code: 34212

Contact Details: Purchase the Sancak Ecza Deposu A.S. report to view the information.

Website: http://www.sancakecza.com.tr

Basic Information
Total Employees:
Purchase the Sancak Ecza Deposu A.S. report to view the information.
Outstanding Shares:
Purchase the Sancak Ecza Deposu A.S. report to view the information.
Incorporation Date:
September 24, 2018
Key Executives
Purchase this report to view the information.
Chairman
Company Performance
Financial values in the chart are available after Sancak Ecza Deposu A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
105.19%
Total operating revenue
105.19%
Operating profit (EBIT)
53.94%
Net Profit (Loss) for the Period
3.72%
Total assets
94.97%
Total equity
139.74%
Operating Profit Margin (ROS)
-1.47%
Net Profit Margin
-1.66%
Return on Equity (ROE)
-38.75%
Debt to Equity Ratio
-56.86%
Quick Ratio
-0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?